GSB Library Collections: Updates
Stay informed of significant changes to library resources. Contact us with feedback or suggestions - we'd love to hear from you!
New Resource: GlobalData Pharma
by Alice Kalinowski on 2024-09-04T12:21:00-07:00 | 0 CommentsCurrent Stanford students, faculty, and staff now have access to the GlobalData Pharma Intelligence Center database. This market research platform covers the pharmaceutical industry and includes databases/modules on drugs, deals, clinical trials, and patents, as well as a report library.
We have access to the following modules:
- Drugs Intelligence (includes drug pipelines, regulatory trackers, drug sales data and forecasts, drug net present value analysis, and more).
- Pricing Intelligence (includes a drug pricing database)
- Trials Intelligence (includes information on clinical trials being conducted around the world, what biomarkers are being used, where the trials are happening and who is involved with them, etc.)
- Therapeutic Analysis (includes narrative reports and forecasts written by industry analysts and an epidemiology/market size database which is helpful for estimating the current and future market size for pharma products)
- Thematic Research (reports focused on key issues, players, and challenges within the bio-pharmaceutical industry)
- Business Fundamentals (includes information about pharmaceutical companies and deals)
You can export some data from the platform, but if you need a larger data extract for your Stanford research project, Ask Us.
Use this link to access GlobalData Pharma Intelligence Center and see GlobalData access help.
Access is made available through a partnership among the GSB Library, Stanford Libraries, and Lane Medical Library.
Add a Comment
Search this Blog
Recent Posts
New Resource: PeakMetrics Data
Resource Update: Academy of Management Journals
New Resource: MSCI ESG Data
New Resource: GlobalData Pharma
New Resource: Preqin Insights+
Subscribe
Enter your e-mail address to receive notifications of new posts by e-mail.
Archive
Return to Blog
0 Comments.